Demographic characteristics of the COVID-19 vaccine trial participant population, mortality population, and individuals fully vaccinated in the United States: A comparative analysis
The purpose of this study was to compare the demographic variables of three populations, COVID-19 vaccine trial participants, COVID-19 deaths, and individuals vaccinated for COVID-19, to determine if the trial participants were appropriately representative. Demographic data (age, sex, race and ethnicity, and presence of comorbidities) were collected from publicly available datasets, organized, and compared. The demographic characteristics of the vaccine clinical trials participants were comparable to those who died due to COVID-19, but less comparable to those who were the first to receive a COVID-19 emergency-use-authorized vaccine
